Position in REPL
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$502,610
+$219,470 QoQ
Shares Held
45,403
+49.0% QoQ
Ownership
0.048%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#80
of 199 holders
Holding Since
Dec 2022
7 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in REPL Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026SEI INVESTMENTS CO holds $1,273,690,748 across 210 Biotechnology names. REPL ranks #116 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ARGX |
Argenx SE
|
255,073 | $236,649,076 | |
| 2 | INSM |
INSMED Inc
|
1,015,870 | $108,312,059 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
129,981 | $64,565,461 | |
| 4 | EXEL |
Exelixis, Inc.
|
1,166,715 | $63,480,962 | |
| 5 | ASND |
Ascendis Pharma A/S
|
237,869 | $63,444,419 | |
| 6 | INCY |
Incyte Corp
|
498,013 | $56,454,752 | |
| 7 | HALO |
Halozyme Therapeutics, Inc.
|
551,116 | $43,135,848 | |
| 8 | REGN |
Regeneron Pharmaceuticals, Inc.
|
60,441 | $37,687,380 |
All Filings in REPL
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $502,610 | 45,403 | Shares | Sole | 2026-08-14 | |
| 2025-06-30 | $283,140 | 30,478 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $317,791 | 32,594 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $147,971 | 12,219 | Shares | Sole | 2025-02-11 | |
| 2023-06-30 | $404,422 | 17,417 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $227,319 | 12,872 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $595,489 | 21,893 | Shares | Defined | 2023-02-10 | |
| No filing history on record for this holder in this stock. | ||||||